Nu Skin Enterprises, Inc. (NUS): who owns it and who trades it
As of Nov 16, 2026, NUS insiders reported 3 open-market sales worth $99.5K and no purchases in the last 12 months, with 82% of the sale value made under pre-set 10b5-1 plans. The largest seller was Edwina D Woodbury (Director), with $41.1K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Nu Skin Enterprises
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NUS
161 funds and institutions reported NUS shares worth $199M at the end of Q2 2026, about 78% of the company. The largest holder is BlackRock, Inc. with 8.9%.
Funds and institutions (13F) 78%Everyone else 22%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 4.32M | 8.89% | $22.8M | +1% |
| American Century Companies Inc | 2.30M | 4.74% | $12.2M | +14% |
| Vanguard Capital Management LLC | 2.05M | 4.22% | $10.8M | -1% |
| Acadian Asset Management LLC | 1.95M | 4.02% | $10.3M | +11% |
| Dimensional Fund Advisors LP | 1.80M | 3.70% | $9.5M | +4% |
| Prescott Group Capital Management, L.L.C. | 1.79M | 3.70% | $9.5M | No change |
| Vanguard Portfolio Management LLC | 1.74M | 3.58% | $9.2M | +2% |
| Renaissance Technologies LLC | 1.61M | 3.31% | $8.5M | -5% |
| Charles Schwab Investment Management Inc | 1.45M | 2.99% | $7.7M | -32% |
| Sixth Street Partners Management Company, L.P. | 1.45M | 2.99% | $7.7M | – |
| CastleKnight Management LP | 1.39M | 2.86% | $7.3M | +44% |
| Geode Capital Management, LLC | 1.27M | 2.61% | $6.7M | +7% |
| Two Sigma Investments, LP | 1.17M | 2.41% | $6.2M | +15% |
| State Street Corp | 1.01M | 2.08% | $5.3M | -2% |
| Prudential Financial Inc | 926,287 | 1.91% | $4.9M | +146% |
| Morgan Stanley | 905,527 | 1.87% | $4.8M | +9% |
| AQR Capital Management LLC | 789,131 | 1.63% | $4M | -36% |
| Citadel Advisors LLC | 654,577 | 1.35% | $3.5M | +188% |
| SG Americas Securities, LLC | 624,990 | 1.29% | $3.3M | – |
| Goldman Sachs Group Inc | 618,642 | 1.27% | $3.3M | -17% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NUS insiders reported $0 of open-market purchases and $99.5K of sales. 82% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | James M Winett | Director | Sale plan | 7,203 | $5.62 | $40.5K | Form 4 |
| Jun 1, 2026 | Edwina D Woodbury | Director | Sale plan | 7,203 | $5.70 | $41.1K | Form 4 |
| May 11, 2026 | Laura Nathanson | Director | Sale | 2,676 | $6.73 | $18K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Edwina D Woodbury | Director | – | $41.1K | Jun 1, 2026 |
| James M Winett | Director | – | $40.5K | Jun 2, 2026 |
| Laura Nathanson | Director | – | $18K | May 11, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NUS short interest
Moderate short interest. 9.2% of NUS shares are sold short: about 1 share in 11. Over the last 12 reports the number of shares short went up 45%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.46M NUS shares were sold short, 9.2% of the shares outstanding, down 1.8% from the report before. At the average daily volume of 393,434 shares, buying them all back would take about 11.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.46M | 9.16% | -2% | 393,434 | 11.3 |
| Oct 15, 2026 | 4.54M | 9.32% | -2% | 484,726 | 9.4 |
| Sep 30, 2026 | 4.62M | 9.49% | -3% | 544,394 | 8.5 |
| Sep 15, 2026 | 4.77M | 9.80% | +5% | 538,607 | 8.8 |
| Aug 31, 2026 | 4.52M | 9.29% | +2% | 483,190 | 9.4 |
| Aug 14, 2026 | 4.44M | 9.13% | -4% | 744,983 | 6.0 |
| Jul 31, 2026 | 4.63M | 9.50% | +11% | 462,459 | 10.0 |
| Jul 15, 2026 | 4.19M | 8.62% | +10% | 699,245 | 6.0 |
| Jun 30, 2026 | 3.80M | 7.82% | +5% | 1.07M | 3.5 |
| Jun 15, 2026 | 3.61M | 7.43% | +17% | 685,493 | 5.3 |
| May 29, 2026 | 3.09M | 6.36% | +0% | 688,170 | 4.5 |
| May 15, 2026 | 3.08M | 6.35% | +16% | 681,634 | 4.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Nu Skin Enterprises company events
Nu Skin Enterprises filed 10 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 21, 2026LeadershipJustin Keisel, the Executive Vice President and President of Global Sales of Nu Skin Enterprises, Inc., began a medical leave of absence. Filing
- Aug 10, 2026ResultsReleased financial results. Filing
- May 29, 2026LeadershipAt the Nu Skin Enterprises, Inc. 2026 Annual Meeting of Stockholders, the Company’s stockholders approved and adopted the Company’s Amended and Restated 2024 Omnibus Incentive Plan, which previously had been approved by the Company’s Board of Directors and its Compensation and Human Capital… Filing
- May 8, 2026LeadershipSteven K. Hatchett notified the Company that, due to family health circumstances, he determined to resign from his position as Executive Vice President and Chief Product Officer, effective as of May 8, 2026. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 27, 2026AgreementNu Skin Enterprises, Inc. entered into that certain Second Amendment and Restatement Agreement in connection with the Second Amended and Restated Credit Agreement by and among the Company, as Borrower, the Lenders from time to time party thereto and Bank of America, N.A., as Administrative Agent… Filing
- Mar 20, 2026LeadershipJames D. Thomas notified Nu Skin Enterprises, Inc. of his resignation from his position as Executive Vice President and Chief Financial Officer, effective on the same date, to pursue an outside opportunity. Filing
- Mar 9, 2026LeadershipThe Board of Directors of Nu Skin Enterprises, Inc. appointed Chayce D. Clark as Executive Vice President, Chief Operating Officer and Chief Legal Officer. Filing
- Feb 12, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Nu Skin Enterprises financials
Famous investors that hold NUS
3 of the 50 well-known investors we track reported holding NUS in their latest 13F filing. The largest position is Jim Simons's, worth $7M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 1.54M | $7M | 0.0% | -5% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 821,185 | $3.7M | 0.0% | +25% |
| Israel Englander · Millennium Management | Q3 2026 | 25,474 | $115K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Nu Skin Enterprises, Inc. (NUS) stock
Who owns the most NUS stock?
The largest reported owner of Nu Skin Enterprises, Inc. (NUS) is BlackRock, Inc., with 8.9% of the company. In total, 161 funds and institutions reported holding NUS at the end of Q2 2026, together about 78% of the shares. See the largest owners.
Are NUS insiders buying or selling?
In the last 12 months, NUS insiders reported no open-market purchases and 3 sales worth $99.5K. The latest trade was on Jun 2, 2026. See every trade.
What is the short interest in NUS?
As of Oct 30, 2026, 4.46M NUS shares were sold short, 9.2% of the shares outstanding, down 1.8% from the report before. At the average daily volume of 393,434 shares, buying them all back would take about 11.3 trading days (days to cover). See the history.
Which famous investors hold NUS?
3 of the 50 well-known investors we track reported NUS in their latest 13F filing, including Jim Simons, Ken Griffin, Israel Englander. The largest position is worth $7M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.